Intellia Therapeutics (NTLA) EPS (Basic) (2015 - 2026)
Intellia Therapeutics (NTLA) posted quarterly EPS (Basic) of -$1.62 for Q1 2026, up 34.16% year-over-year from -$1.21 in Q1 2025, and down 90.46% quarter-over-quarter from -$0.85 in Q4 2025.
Intellia Therapeutics (NTLA) EPS (Basic) (2015 - 2026) Analysis & Trends
Intellia Therapeutics (NTLA) has reported EPS (Basic) for 12 consecutive years, with -$1.62 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 34.16% year-over-year to -$1.62; the TTM figure through Mar 2026 stood at -$5.28 (up 18.19% YoY), while the FY2025 annual figure was -$12.24, up 4.71% from the prior year.
- EPS (Basic) declined to -$1.62 in Q1 2026 per NTLA's latest filing, from -$0.85 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.85 in Q4 2025 and bottomed at -$7.27 in Q4 2022.
- Historically, EPS (Basic) has averaged -$2.28 across 5 years, with a median of -$1.82 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 99.87% — and 2025, when it tumbled 82.36%.
- Intellia Therapeutics' EPS (Basic) stood at -$7.27 in 2022, then surged by 74.68% to -$1.84 in 2023, then soared by 30.64% to -$1.28 in 2024, then surged by 33.29% to -$0.85 in 2025, then plunged by 90.46% to -$1.62 in 2026.
- Business Quant data shows NTLA's EPS (Basic) at -$1.62 in Q1 2026, -$0.85 in Q4 2025, and -$2.02 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Intellia Therapeutics | 1.67 Bn | 1.67 Bn | - | -1.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.45 |
| Mar 31, 2026 | -1.62 |
| Dec 31, 2025 | -0.85 |
| Sep 30, 2025 | -2.02 |
| Jun 30, 2025 | -1.14 |
| Mar 31, 2025 | -2.46 |
| Dec 31, 2024 | -1.28 |
| Sep 30, 2024 | -1.42 |
| Jun 30, 2024 | -1.47 |
| Mar 31, 2024 | -1.35 |
| Dec 31, 2023 | -1.84 |
| Sep 30, 2023 | -1.78 |
| Jun 30, 2023 | -2.14 |
| Mar 31, 2023 | -1.82 |
| Dec 31, 2022 | -7.27 |
| Sep 30, 2022 | -2.90 |
| Jun 30, 2022 | -2.68 |
| Mar 31, 2022 | -4.66 |
| Dec 31, 2021 | -5,426.31 |
| Sep 30, 2021 | -9.14 |